INNOVITA (688253)
Innovita Biological Technology Co., Ltd., a biopharmaceutical enterprise, engages in research and development, production and sales of POCT rapid diagnostic pro...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
INNOVITA Analyst Rating
View moreForecast & Rating
May 5, 2026Price forecast
¥53.810.77%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- AASTOCKS News · Jun 1 at 04:37 AM
HSI Up 220 pts at Half-day; MEITUAN-W Surges Over 6% Ahead of Results; MINIMAX-W Slumps Over 14%
- Zhitong · Oct 30, 2025 at 09:42 AM
INNOVITA released its performance for the first three quarters, with a net profit attributable to the parent company of 131 million yuan, a year-on-year decrease of 46.37%
- Zhitong · Aug 28, 2025 at 01:36 PM
INNOVITA: Net profit in the first half of the year was 125 million yuan, a year-on-year decrease of 39.36%
- Zhitong · Jul 21, 2025 at 03:57 AM
INNOVITA establishes a new health technology company
- Zhitong · Jul 18, 2025 at 08:03 AM
INNOVITA's subsidiary recently obtained a qualification
- Zhitong · Jun 23, 2025 at 08:55 AM
INNOVITA obtained qualification for 1 product
